Getlink


27/11/19 -"Following the 9m 19 release, our valuation is unchanged as a result of the maintained EBITDA guidance. However, we have decreased our expected net profit going forward due to higher depreciation ..."

Pages
52
Language
English
Published on
27/11/19
You may also be interested by these reports :
21/10/25
In Q3 2025, group revenue was €472 million, nearly unchanged from €475 million in Q3 2024, aligning with our expectations. Despite the stable ...

14/10/25
The target price has reset lower to reflect our more cautious stance while we await clearer evidence that the current growth trajectory can fully ...

30/09/25
Listening to ADP (ADD; France)’s earnings calls can be baffling for concession investors. Management spends as much time talking about “premium ...

10/09/25
Sacyr runs on fairly thin margins, so even a small movement in operating profit can cause a large percentage swing at the net profit line. That’s why ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO